Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in BMJ

Retrieve available abstracts of 138 articles:
HTML format

Single Articles

    March 2021
    Drug company Servier is found guilty of manslaughter and aggravated deceit over Mediator diabetes drug.
    BMJ. 2021;372:n873.

  2. AYOUBKHANI D, Khunti K, Nafilyan V, Maddox T, et al
    Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study.
    BMJ. 2021;372:n693.
    PubMed     Abstract available

  3. JONES A, Wu JHY, Buse K
    UK's sugar tax hits the sweet spot.
    BMJ. 2021;372:n463.

    January 2021
  4. PALMER SC, Tendal B, Mustafa RA, Vandvik PO, et al
    Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2021;372:m4573.
    PubMed     Abstract available

  5. GOLDENBERG JZ, Day A, Brinkworth GD, Sato J, et al
    Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data.
    BMJ. 2021;372:m4743.
    PubMed     Abstract available

  6. DOWNS J
    Please see the whole picture of my eating disorder.
    BMJ. 2021;372:m4569.

    December 2020
  7. DELICANO RA, Hammar U, Egenvall A, Westgarth C, et al
    The shared risk of diabetes between dog and cat owners and their pets: register based cohort study.
    BMJ. 2020;371:m4337.
    PubMed     Abstract available

    November 2020
    Every hospital should have a specialist diabetes inpatient team, says review.
    BMJ. 2020;371:m4441.

  9. MUSSO G, Saba F, Cassader M, Gambino R, et al
    Diabetic ketoacidosis with SGLT2 inhibitors.
    BMJ. 2020;371:m4147.

    September 2020
  10. HILL NE, Oliver NS
    Evolving type 1 diabetes in distinguishing between type 1 and type 2 diabetes.
    BMJ. 2020;370:m3772.

  11. FILION KB, Lix LM, Yu OH, Dell'Aniello S, et al
    Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.
    BMJ. 2020;370:m3342.
    PubMed     Abstract available

    August 2020
  12. FRALICK M, Kim SC, Schneeweiss S, Everett BM, et al
    Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study.
    BMJ. 2020;370:m2812.
    PubMed     Abstract available

  13. BUTLER AE, Misselbrook D
    Distinguishing between type 1 and type 2 diabetes.
    BMJ. 2020;370:m2998.

    July 2020
  14. CAI X, Zhang Y, Li M, Wu JH, et al
    Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
    BMJ. 2020;370:m2297.
    PubMed     Abstract available

  15. HU Y, Ding M, Sampson L, Willett WC, et al
    Intake of whole grain foods and risk of type 2 diabetes: results from three prospective cohort studies.
    BMJ. 2020;370:m2206.
    PubMed     Abstract available

  16. ZHENG JS, Sharp SJ, Imamura F, Chowdhury R, et al
    Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries.
    BMJ. 2020;370:m2194.
    PubMed     Abstract available

  17. BURNS VF
    I live with "the world's most dangerous" eating disorder.
    BMJ. 2020;370:m1886.

    June 2020
  18. MCMILLAN B, Boyd J, Mitchell C
    Enhancing postnatal care of women with gestational diabetes.
    BMJ. 2020;369:m2414.

  19. KAR P
    Partha Kar: Covid-19-time for parity in commissioning diabetes services.
    BMJ. 2020;369:m2154.

    May 2020
  20. VOUNZOULAKI E, Khunti K, Abner SC, Tan BK, et al
    Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis.
    BMJ. 2020;369:m1361.
    PubMed     Abstract available

  21. RICHARDSON TG, Sanderson E, Elsworth B, Tilling K, et al
    Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
    BMJ. 2020;369:m1203.
    PubMed     Abstract available

    April 2020
  22. BHASALE A, Mintzes B, Sarpatwari A
    Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.
    BMJ. 2020;369:m1107.

  23. PASTERNAK B, Wintzell V, Melbye M, Eliasson B, et al
    Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study.
    BMJ. 2020;369:m1186.
    PubMed     Abstract available

  24. LI Y, Teng D, Shi X, Qin G, et al
    Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.
    BMJ. 2020;369:m997.
    PubMed     Abstract available

  25. MATHIESON S, Lin CC, Underwood M, Eldabe S, et al
    Pregabalin and gabapentin for pain.
    BMJ. 2020;369:m1315.

  26. DIAB J, Bannan A, Pollitt T
    Necrotising fasciitis.
    BMJ. 2020;369:m1428.

    March 2020

  27. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
    BMJ. 2020;368:m1270.

    Covid-19: diabetes clinicians set up social media account to help alleviate patients' fears.
    BMJ. 2020;368:m1262.

    Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
    BMJ. 2020;368:m1174.

    Rapid access to multidisciplinary diabetes foot care teams.
    BMJ. 2020;368:m773.

    February 2020
  31. MCCORMACK JP, Holmes DT
    Your results may vary: the imprecision of medical measurements.
    BMJ. 2020;368:m149.

  32. ROY MP
    Improving nutrition in India: encouraging informed food choices.
    BMJ. 2020;368:m367.

    Healthy lifestyle and life expectancy: fund prevention programmes to end the cycle of preventable morbidity.
    BMJ. 2020;368:m427.

  34. CRAIG MF
    We shouldn't recommend harmful foods "in moderation".
    BMJ. 2020;368:m365.

    January 2020
    Hope for diabetes: five minutes with David Unwin.
    BMJ. 2020;368:m404.

  36. COOK R, Davidson P, Martin R
    Losing weight following diagnosis of type 2 diabetes boosts chance of remission.
    BMJ. 2020;368:l6775.
    PubMed     Abstract available

  37. KAR P
    Partha Kar: What will the 2020s hold for diabetes care?
    BMJ. 2020;368:m202.

  38. LI Y, Schoufour J, Wang DD, Dhana K, et al
    Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study.
    BMJ. 2020;368:l6669.
    PubMed     Abstract available

    December 2019
  39. YU Y, Arah OA, Liew Z, Cnattingius S, et al
    Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up.
    BMJ. 2019;367:l6398.
    PubMed     Abstract available

    November 2019
  40. RODRIGUEZ-GUTIERREZ R, Gonzalez-Gonzalez JG, Zuniga-Hernandez JA, McCoy RG, et al
    Benefits and harms of intensive glycemic control in patients with type 2 diabetes.
    BMJ. 2019;367:l5887.
    PubMed     Abstract available

    October 2019
  41. MIRZAZADEH M, Alijani E, Fani M, Jamili S, et al
    A 44 year old woman with episodic sweating and hypertension.
    BMJ. 2019;367:l5879.

  42. SPILSBURY C, Panahi M, Bowsher G, Sadighi A, et al
    A young woman with dyspnoea and oedema.
    BMJ. 2019;367:l5763.

    Diabetes technology: specialists are blocking access for some patients, say experts.
    BMJ. 2019;367:l6085.

  44. Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis.
    BMJ. 2019;367:l5612.

    Thousands more patients with type 1 diabetes are getting flash glucose devices, data show.
    BMJ. 2019;367:l5895.

    September 2019
    Whether one burns fat, and not the type of fat one eats, is the important thing in type 2 diabetes.
    BMJ. 2019;366:l5700.

  47. HOOPER L, Brown T, Brainard J, Abdelhamid A, et al
    Authors' reply to Henderson.
    BMJ. 2019;366:l5703.

  48. LEAN M, McCombie L, McSorely J
    Trends in type 2 diabetes.
    BMJ. 2019;366:l5407.

  49. MAGLIANO DJ, Islam RM, Barr ELM, Gregg EW, et al
    Trends in incidence of total or type 2 diabetes: systematic review.
    BMJ. 2019;366:l5003.
    PubMed     Abstract available

    August 2019
  50. PASTERNAK B, Ueda P, Eliasson B, Svensson AM, et al
    Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
    BMJ. 2019;366:l4772.
    PubMed     Abstract available

  51. LIND M, Pivodic A, Svensson AM, Olafsdottir AF, et al
    HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.
    BMJ. 2019;366:l4894.
    PubMed     Abstract available

  52. BROWN TJ, Brainard J, Song F, Wang X, et al
    Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials.
    BMJ. 2019;366:l4697.
    PubMed     Abstract available

  53. MAHASE E
    Progress in diabetes care has not improved outcomes in US, study finds.
    BMJ. 2019;366:l5166.

    July 2019
  54. MERINO J
    Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis.
    BMJ. 2019;366:l4292.
    PubMed     Abstract available

  55. NEUENSCHWANDER M, Ballon A, Weber KS, Norat T, et al
    Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies.
    BMJ. 2019;366:l2368.
    PubMed     Abstract available

  56. JIAO J, Liu G, Shin HJ, Hu FB, et al
    Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies.
    BMJ. 2019;366:l4009.
    PubMed     Abstract available

    June 2019
  57. WISE J
    The wrong diabetes: how C peptide testing might help.
    BMJ. 2019;365:l4352.

  58. SHEIKH Z, Akali A
    An unstable lump in the groin.
    BMJ. 2019;365:l2214.

    May 2019
  59. KARSLIOGLU FRENCH E, Donihi AC, Korytkowski MT
    Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients.
    BMJ. 2019;365:l1114.
    PubMed     Abstract available

    April 2019
  60. MAHASE E
    Dentists could help detect diabetes and cardiovascular disease during oral health checks.
    BMJ. 2019;365:l1870.

  61. BARRY E, Finnikin S
    A borderline HBA1c result.
    BMJ. 2019;365:l1361.

  62. WEI L, Lai EC, Kao-Yang YH, Walker BR, et al
    Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: population based cohort study.
    BMJ. 2019;365:l1204.
    PubMed     Abstract available

  63. MUSSO G, Gambino R, Cassader M, Paschetta E, et al
    Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.
    BMJ. 2019;365:l1328.
    PubMed     Abstract available

  64. BLAIR JC, McKay A, Ridyard C, Thornborough K, et al
    Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    BMJ. 2019;365:l1226.
    PubMed     Abstract available

    March 2019
  65. WISE J
    The BMJ Awards 2019: Diabetes Team of the Year.
    BMJ. 2019;364:l1232.

    Sixty seconds on . . . reversing type 2 diabetes.
    BMJ. 2019;364:l1128.

  67. NEWMAN M
    Questions over future of global diabetes group as founding members resign.
    BMJ. 2019;364:l995.

    February 2019
  68. LEVY M, Prentice M, Wass J
    Diabetes insipidus.
    BMJ. 2019;364:l321.

    Australian MPs visit Southport GP to learn about low carb diet for type 2 diabetes.
    BMJ. 2019;364:l659.

  70. SCIBILIA R, Aldred C
    BMJ. 2019;364:k5258.

    January 2019
    Fried food linked to increased risk of death among older US women.
    BMJ. 2019;364:l362.

    Sixty seconds on . . . medical detection dogs.
    BMJ. 2019;364:l302.

  73. MAYOR S
    Delivering diabetes targets: five minutes with . . . Sam Everington.
    BMJ. 2019;364:l229.

  74. MANFREDINI R, Cappadona R, Fabbian F
    Nurses, shift work, and diabetes: should late chronotype be considered as a risk factor?
    BMJ. 2019;364:l178.

    Shift work and diabetes: alcohol consumption as a risk factor.
    BMJ. 2019;364:l177.

  76. SHAN Z, Bhupathiraju SN
    Authors' reply to Skovenborg and Manfredini and colleagues.
    BMJ. 2019;364:l179.

  77. PILLING LC, Tamosauskaite J, Jones G, Wood AR, et al
    Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.
    BMJ. 2019;364:k5222.
    PubMed     Abstract available

  78. MAYOR S
    Diabetes: precision approach will improve outcomes, says research director.
    BMJ. 2019;364:l186.

    Helen Salisbury: When policy doesn't match evidence.
    BMJ. 2019;364:l54.

    December 2018
    Everyone with type 1 diabetes should have access to a flash glucose device.
    BMJ. 2018;363:k5204.

  81. BLACK S
    Flash glucose monitoring devices: CCG criteria are incoherent.
    BMJ. 2018;363:k5203.

  82. ADLER AI
    Incretins and cancer of the bile duct in type 2 diabetes.
    BMJ. 2018;363:k5155.

  83. ABRAHAMI D, Douros A, Yin H, Yu OH, et al
    Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.
    BMJ. 2018;363:k4880.
    PubMed     Abstract available

    November 2018
    Type 2 diabetes: 5000 patients to test feasibility of "remission service".
    BMJ. 2018;363:k5114.

    Are you well controlled?
    BMJ. 2018;363:k3119.

  86. SHAN Z, Li Y, Zong G, Guo Y, et al
    Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses.
    BMJ. 2018;363:k4641.
    PubMed     Abstract available

    Type 2 diabetes affects 7000 young people in England and Wales, analysis shows.
    BMJ. 2018;363:k4929.

    Type 2 diabetes: sweetened drinks pose greater risk than other sugary foods.
    BMJ. 2018;363:k4943.

  89. CHOO VL, Viguiliouk E, Blanco Mejia S, Cozma AI, et al
    Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies.
    BMJ. 2018;363:k4644.
    PubMed     Abstract available

  90. SODI R, McKay K, Dampetla S, Pappachan JM, et al
    Monitoring glycaemic control in patients with diabetes mellitus.
    BMJ. 2018;363:k4723.

    SGLT2 inhibitors for diabetes are linked to increased risk of lower limb amputation.
    BMJ. 2018;363:k4828.

  92. UEDA P, Svanstrom H, Melbye M, Eliasson B, et al
    Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
    BMJ. 2018;363:k4365.
    PubMed     Abstract available

    NHS England tells CCGs to end postcode lottery over diabetes glucose devices.
    BMJ. 2018;363:k4812.

  94. OWEN J
    Audit paints "bleak picture" of diabetes care in England and Wales.
    BMJ. 2018;363:k4780.

    Patients with type 1 diabetes are missing out on flash glucose devices, finds BMJ investigation.
    BMJ. 2018;363:k4675.

  96. MILLETT ERC, Peters SAE, Woodward M
    Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants.
    BMJ. 2018;363:k4247.
    PubMed     Abstract available

    October 2018
  97. KHANDWALA YS, Baker VL, Shaw GM, Stevenson DK, et al
    Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States: population based cohort study.
    BMJ. 2018;363:k4372.
    PubMed     Abstract available

    September 2018
  98. MIETTINEN ME, Virtanen SM
    Dietary gluten and type 1 diabetes.
    BMJ. 2018;362:k3867.

  99. ANTVORSKOV JC, Halldorsson TI, Josefsen K, Svensson J, et al
    Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark.
    BMJ. 2018;362:k3547.
    PubMed     Abstract available

  100. RAMOS R, Comas-Cufi M, Marti-Lluch R, Ballo E, et al
    Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
    BMJ. 2018;362:k3359.
    PubMed     Abstract available

  101. XU G, Liu B, Sun Y, Du Y, et al
    Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.
    BMJ. 2018;362:k1497.
    PubMed     Abstract available

    August 2018
  102. MAYOR S
    Type 1 diabetes: earlier onset is linked to cardiovascular complications and reduced lifespan.
    BMJ. 2018;362:k3487.

  103. WISE J
    Diabetes: simple patient characteristics should help inform choice of second line drug, study finds.
    BMJ. 2018;362:k3368.

    July 2018
  104. MCGOWAN LD, Roumie CL
    Sulfonylureas as second line treatment for type 2 diabetes.
    BMJ. 2018;362:k3041.

  105. DOUROS A, Dell'Aniello S, Yu OHY, Filion KB, et al
    Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.
    BMJ. 2018;362:k2693.
    PubMed     Abstract available

  106. FEGHALI MN, Scifres CM
    Novel therapies for diabetes mellitus in pregnancy.
    BMJ. 2018;362:k2034.
    PubMed     Abstract available

  107. LUDVIGSSON JF, Neovius M, Soderling J, Gudbjornsdottir S, et al
    Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden.
    BMJ. 2018;362:k2638.
    PubMed     Abstract available

    June 2018
  108. ABALEM MF, Eagle KA, Rao RC
    Unilateral retinopathy in a patient with diabetes and coronary heart disease.
    BMJ. 2018;361:k1703.

  109. FOROUHI NG, Misra A, Mohan V, Taylor R, et al
    Dietary and nutritional approaches for prevention and management of type 2 diabetes.
    BMJ. 2018;361:k2234.

    May 2018
  110. DOBSON R, Whittaker R, Jiang Y, Maddison R, et al
    Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial.
    BMJ. 2018;361:k1959.
    PubMed     Abstract available

    April 2018
  111. CARRUTH L, Mendenhall E
    Social aetiologies of type 2 diabetes.
    BMJ. 2018;361:k1795.

  112. STAERK L, Wang B, Preis SR, Larson MG, et al
    Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
    BMJ. 2018;361:k1453.
    PubMed     Abstract available

  113. WAUGH N, Adler A, Craigie I, Omer T, et al
    Closed loop systems in type 1 diabetes.
    BMJ. 2018;361:k1613.

  114. BEKIARI E, Kitsios K, Thabit H, Tauschmann M, et al
    Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
    BMJ. 2018;361:k1310.
    PubMed     Abstract available

    March 2018
  115. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status, non-communicable disease risk factors, and walking speed in older adults: multi-cohort population based study.
    BMJ. 2018;360:k1046.
    PubMed     Abstract available

  116. HAWKES N
    Sixty seconds on . . . diabetes.
    BMJ. 2018;360:k1264.

  117. ABRAHAMI D, Douros A, Yin H, Yu OHY, et al
    Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.
    BMJ. 2018;360:k872.
    PubMed     Abstract available

  118. WISE J
    NHS diabetes prevention programme helps weight loss, analysis shows.
    BMJ. 2018;360:k1196.

    February 2018
  119. PATORNO E, Goldfine AB, Schneeweiss S, Everett BM, et al
    Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study.
    BMJ. 2018;360:k119.
    PubMed     Abstract available

  120. MORLEY RL, Sharma A, Horsch AD, Hinchliffe RJ, et al
    Peripheral artery disease.
    BMJ. 2018;360:j5842.

    January 2018
  121. TU H, Wen CP, Tsai SP, Chow WH, et al
    Cancer risk associated with chronic diseases and disease markers: prospective cohort study.
    BMJ. 2018;360:k134.
    PubMed     Abstract available

  122. WISE J
    NHS weight management programme makes clinical difference in patients with type 2 diabetes.
    BMJ. 2018;360:k177.

  123. WENG J, Zhou Z, Guo L, Zhu D, et al
    Incidence of type 1 diabetes in China, 2010-13: population based study.
    BMJ. 2018;360:j5295.
    PubMed     Abstract available

    December 2017
    GP based weight loss programme can reverse type 2 diabetes.
    BMJ. 2017;359:j5641.

  125. WISE J
    Study links varicoceles to heart disease and diabetes.
    BMJ. 2017;359:j5569.

    November 2017
  126. HIPPISLEY-COX J, Coupland C
    Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    BMJ. 2017;359:j5019.
    PubMed     Abstract available

  127. MISHRA SC, Chhatbar KC, Kashikar A, Mehndiratta A, et al
    Diabetic foot.
    BMJ. 2017;359:j5064.

  128. HAWKES N
    Sixty seconds on . . . semaglutide.
    BMJ. 2017;359:j5010.

    October 2017
  129. KALLIALA I, Markozannes G, Gunter MJ, Paraskevaidis E, et al
    Obesity and gynaecological and obstetric conditions: umbrella review of the literature.
    BMJ. 2017;359:j4511.
    PubMed     Abstract available

  130. MAYOR S
    Type 3c diabetes associated with pancreatic disease is often misdiagnosed, finds study.
    BMJ. 2017;359:j4923.

  131. MAYOR S
    GP referral to prevention programme helps prevent type 2 diabetes, study finds.
    BMJ. 2017;359:j4770.

  132. MARJOT D
    Hunger can be the driving force behind "relapse" of type 2 diabetes.
    BMJ. 2017;359:j4728.

  133. COUSINS S
    Diabetic patients with poor glycaemic control have higher risk of latent TB, study shows.
    BMJ. 2017;359:j4767.

    September 2017
  134. MAYOR S
    Obesity surgery achieves long term weight loss and prevents type 2 diabetes, study finds.
    BMJ. 2017;358:j4376.

  135. GULLAND A
    People at high risk of diabetes should undergo intensive lifestyle change, says NICE.
    BMJ. 2017;358:j4301.

  136. MAYOR S
    Twenty four hour glucose monitoring halves adverse birth outcomes in pregnant women with type 1 diabetes, study finds.
    BMJ. 2017;358:j4294.

  137. MCCOMBIE L, Leslie W, Taylor R, Kennon B, et al
    Beating type 2 diabetes into remission.
    BMJ. 2017;358:j4030.

  138. DYER O
    France to prosecute its drug regulator and Servier in scandal over diabetes drug.
    BMJ. 2017;358:j4231.

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.